MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution
- PMID: 38512415
- PMCID: PMC11093610
- DOI: 10.1172/JCI172826
MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution
Abstract
Fibrosis following tissue injury is distinguished from normal repair by the accumulation of pathogenic and apoptosis-resistant myofibroblasts (MFs), which arise primarily by differentiation from resident fibroblasts. Endogenous molecular brakes that promote MF dedifferentiation and clearance during spontaneous resolution of experimental lung fibrosis may provide insights that could inform and improve the treatment of progressive pulmonary fibrosis in patients. MAPK phosphatase 1 (MKP1) influences the cellular phenotype and fate through precise and timely regulation of MAPK activity within various cell types and tissues, yet its role in lung fibroblasts and pulmonary fibrosis has not been explored. Using gain- and loss-of-function studies, we found that MKP1 promoted lung MF dedifferentiation and restored the sensitivity of these cells to apoptosis - effects determined to be mainly dependent on MKP1's dephosphorylation of p38α MAPK (p38α). Fibroblast-specific deletion of MKP1 following peak bleomycin-induced lung fibrosis largely abrogated its subsequent spontaneous resolution. Such resolution was restored by treating these transgenic mice with the p38α inhibitor VX-702. We conclude that MKP1 is a critical antifibrotic brake whose inhibition of pathogenic p38α in lung fibroblasts is necessary for fibrosis resolution following lung injury.
Keywords: Cell biology; Fibrosis; Molecular biology; Protein kinases; Pulmonology.
Conflict of interest statement
Figures
Similar articles
-
KLF4 is a therapeutically tractable brake on fibroblast activation that promotes resolution of pulmonary fibrosis.JCI Insight. 2022 Aug 22;7(16):e160688. doi: 10.1172/jci.insight.160688. JCI Insight. 2022. PMID: 35852857 Free PMC article.
-
Notch3 Deficiency Attenuates Pulmonary Fibrosis and Impedes Lung-Function Decline.Am J Respir Cell Mol Biol. 2021 Apr;64(4):465-476. doi: 10.1165/rcmb.2020-0516OC. Am J Respir Cell Mol Biol. 2021. PMID: 33493092
-
Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.Biochem Pharmacol. 2021 Jan;183:114356. doi: 10.1016/j.bcp.2020.114356. Epub 2020 Dec 4. Biochem Pharmacol. 2021. PMID: 33285108
-
Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis.Circulation. 2017 Aug 8;136(6):549-561. doi: 10.1161/CIRCULATIONAHA.116.026238. Epub 2017 Mar 29. Circulation. 2017. PMID: 28356446 Free PMC article.
-
Sphingolipids in pulmonary fibrosis.Adv Biol Regul. 2015 Jan;57:55-63. doi: 10.1016/j.jbior.2014.09.008. Epub 2014 Oct 13. Adv Biol Regul. 2015. PMID: 25446881 Free PMC article. Review.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous